STOCK-BASED COMPENSATION (Tables)

6 Months Ended

Jun. 30, 2026

Share-Based Payment Arrangement [Abstract]

Stock option activity for the six months ended June 30, 2026 was as follows.


	Options on Common Stock	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (years)	Aggregate Intrinsic Value
Outstanding (vested and expected to vest) as of December 31, 2025	1,975,648	$	1.74	7.47	$	17,869
Granted	2,050,158	6.63
Exercised	(287,876)	0.42			2,061
Forfeited, canceled, or expired	(3,662)	0.57
Outstanding (vested and expected to vest) as of June 30, 2026	3,734,268	$	4.53	8.8	$	11,822
Exercisable as of June 30, 2026	769,657	$	0.63	6.0	$	5,349

Schedule of Black-Scholes Option Pricing Model Weighted-Average Assumptions

The Black-Scholes option-pricing model was used to estimate the fair value of the warrants with the following assumptions:


	Initial Placement Underwriters' Warrants		Over-allotment Exercise Underwriters' Warrants
Risk-free interest rate	3.94	%	3.96	%
Expected term	5 years		4.96 years
Volatility of common stock	78.83	%	78.94	%
Expected dividend rate	—	%	—	%

The following table summarizes the weighted-average assumptions used in the Black-Scholes option pricing model for stock options granted during the three and six months ended June 30, 2026 and 2025.


	Three Months Ended June 30,		Six Months Ended June 30,
	2026	2025	2026	2025
Risk-free interest rate	4.26 %	3.87 %	4.19 %	3.87 %
Expected term	6.08 years	5.99 years	6.01 years	5.99 years
Volatility of common stock	76.0 %	78.2 %	76.2 %	78.2 %
Expected dividend rate	— %	— %	— %	— %
Fair value per share of common stock	$6.90	$2.00	$6.63	$2.00

Stock-based Compensation Expense for Employees and Non-employees

The Company

recognized total stock-based compensation expense for employees and non-employees as components of the statement of operations and comprehensive loss as follows.


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Costs of revenue	$	11	$	1	$	36	$	5
Selling and marketing	41		3		45		14
Research and development	146		57		236		100
General and administrative	365		109		594		203
Total stock-based compensation expense	$	563	$	170	$	911	$	322

Schedule of Restricted Stock Units


	Restricted Stock Units	Weighted Average Grant Date Fair Value per Share
Outstanding (expected to vest) as of December 31, 2025	—
Granted	24,270	$	6.18
Vested	(12,132)

Outstanding (expected to vest) as of June 30, 2026	12,138